Luke Lavallée

Dr. Luke Lavallée is an Assistant Professor at the University of Ottawa’s Faculty of Medicine and a Urologic Oncologist at The Ottawa Hospital. He holds a cross-appointment in the School of Epidemiology and Public Health and is an Associate Scientist at the Ottawa Hospital Research Institute’s Clinical Epidemiology Program. His primary roles include clinical practice, research, and teaching in urologic oncology, with a focus on kidney, bladder, and prostate cancers.

Education:

• Doctor of Medicine & Master of Surgery (MDCM), McGill University (2008)
• Bachelor of Science (Honors Biochemistry), McGill University (2004)
• Urology Residency, University of Ottawa (completion not specified)
• Urologic Oncology Fellowship and Master of Science (Epidemiology), University of Ottawa (2015)
• Fellow of the Royal College of Surgeons of Canada (FRCSC) in Urology (2013)

Research Interests: Dr. Lavallée’s work spans urologic oncology, robotic surgery, and epidemiology. He focuses on improving outcomes for patients with kidney, bladder, and prostate cancers through clinical trials, observational studies, and evidence-based decision aids. His research also emphasizes population health, health promotion, and knowledge translation in surgical oncology.

Awards & Grants: He has received multiple awards and grants for his contributions to cancer research, though specific names are not listed. His work aligns with organizations like the Kidney Cancer Research Network of Canada and the International Evidence-Based Urology Group.

Labs/Teams: Affiliated with the Ottawa Hospital Research Institute’s Clinical Epidemiology Program and collaborates with multidisciplinary teams in urologic oncology and surgical innovation.